INNV Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
InnovAge Holding Corp (INNV) is not a strong buy at this time for a beginner investor with a long-term focus. While the stock has shown recent price momentum and bullish technical indicators, the company's financial performance, particularly the significant drop in net income and EPS, raises concerns. Additionally, hedge funds are selling the stock, and there is no significant positive sentiment or catalysts from analysts or news. Given the user's impatience and unwillingness to wait for optimal entry points, holding off on investing in INNV is advisable until more favorable conditions emerge.
The stock shows bullish technical indicators with a positively expanding MACD histogram (0.0605), overbought RSI (80.312), and bullish moving averages (SMA_5 > SMA_20 > SMA_200). The stock closed above key resistance levels (R1: 9.13, R2: 9.496), indicating strong momentum. However, the overbought RSI suggests a potential pullback in the near term.
Bullish technical indicators and recent price momentum with a 4.49% regular market gain and 1.99% post-market gain.
Hedge funds are selling the stock with a 105.94% increase in selling activity over the last quarter. Financial performance shows a significant drop in net income (-180.31% YoY) and EPS (-180.00% YoY). Analysts maintain an Underweight rating, and there is no recent positive news or significant insider activity.
In Q2 2026, revenue increased by 14.69% YoY to $239.7M, but net income dropped by -180.31% YoY to $10.6M, and EPS fell by -180.00% YoY to $0.08. Gross margin improved by 32.01% YoY to 20%.
JPMorgan raised the price target to $7 from $5 but maintained an Underweight rating, reflecting a cautious outlook on the stock.
